Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07494916
Active, not recruiting Not applicable

Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia

NCT07494916 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-02-02
Last updated
2026-03-27

Condition(s) studied

SarcopeniaAgingPhysical Functional PerformanceMuscle Weakness | Patient

Investigational drug(s) / intervention(s)

Functional Task Training in Power ZonesStandard Functional Task TrainingTraditional Resistance Training

Functional Task Training in Power Zones: Participants will perform a 12-week Functional Task Training (FTT) program (2 sessions/week, 60 min/session). The circuit includes 4 specific functional tasks designed to simulate daily life demands: 1) Sit-to-stand from a chair, 2) Walking with changes of direction, 3) Lifting and carrying objects, and 4) Pulling/pushing movements. All exercises will be executed using a Functional Electromechanical Dynamometer (DEMF). This device provides constant electronic resistance and allows for the determination of the individual load that elicits peak power output. Training intensity will be strictly monitored to ensure participants perform each repetition within their optimal muscle power zone. Loads will be adjusted progressively (5-10% weekly) based on the velocity and power data provided by the device. Each session includes a warm-up, 3 sets of 10-12 repetitions per task, and a cool-down.

Standard Functional Task Training: Participants will perform a 12-week Functional Task Training (FTT) program (2 sessions/week, 60 min/session). The circuit includes 4 specific functional tasks: 1) Sit-to-stand from a chair, 2) Walking with changes of direction, 3) Lifting and carrying objects, and 4) Pulling/pushing movements. All exercises will be executed using the Functional Electromechanical Dynamometer (DEMF). Training follows standard progressive resistance protocols (5-10% weekly load increase) based on individual tolerance, without specifically targeting or monitoring the optimal muscle power zones.

Traditional Resistance Training: Participants will complete a 12-week traditional resistance training program (2 sessions/week, 60 min/session). The protocol targets major muscle groups through 4 conventional analytical exercises (e.g., leg press, chest press, row, and leg extension). These exercises will be performed using the DEMF device to control and monitor the training loads. This group does not perform functional task simulations or power-zone specific training, following a standard hypertrophy and strength progression.

Study summary

Sarcopenia is a condition associated with aging that causes a loss of muscle mass, strength, and physical function. This decline limits the ability to perform basic daily activities and increases the risk of falls and dependency.

The purpose of this clinical study is to determine the effects of a 12-week Functional Task Training (FTT) program on functional, structural, and physiological biomarkers in older adults with sarcopenia. FTT involves practicing everyday movements, such as standing up from a chair, climbing stairs, walking, and carrying objects.

The study aims to answer the following question: Does Functional Task Training performed specifically in optimal muscle power zones offer greater improvements in aging biomarkers compared to standard Functional Task Training or traditional resistance training?

The researchers hypothesize that while all exercise interventions will be beneficial, the FTT program focused on power zones will generate the greatest improvements in functional, physiological, and structural biomarkers in older adults with sarcopenia.

To test this, 30 older adults (aged 60 and older) will be randomly assigned to one of three active groups for a 12-week period (2 days per week): an FTT group training in power zones, a standard FTT group, or a traditional resistance training group. All exercise groups will use a Functional Electromechanical Dynamometer (DEMF) to precisely measure and control the training loads.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Participants aged 60 years or older. Diagnosis of probable or confirmed sarcopenia (according to EWGSOP2 criteria, including low handgrip strength and/or low muscle mass). Ability to walk independently (with or without assistive devices). Medically cleared to participate in a structured physical exercise program. Voluntary participation and signed informed consent. Exclusion Criteria: Unstable cardiovascular disease, uncontrolled hypertension, or any medical condition where exercise is contraindicated. Recent bone fractures or major surgeries within the last 6 months that limit physical activity. Severe visual or auditory deficits that interfere with the training sessions. Concurrent participation in another structured resistance training or functional exercise program. Any musculoskeletal or neurological condition that prevents the safe use of the Functional Electromechanical Dynamometer (DEMF)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Lab. IDAFISAD CTS 642 Faculty of Sports Science, Granada Granada Granada

More Universidad de Granada trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07494916 on ClinicalTrials.gov ↗ ← All trials in Spain